Zimmer Biomet Holdings Inc. has completed its acquisition of Monogram Technologies Inc., an AI-driven orthopedic robotics company. Monogram brings advanced surgeon-guided semi- and fully autonomous robotic technologies to Zimmer Biomet's portfolio, strengthening its position in orthopedic robotics and navigation. Monogram's CT-based, semi-autonomous, AI-navigated total knee arthroplasty robotic system received FDA 510(k) clearance in March 2025 and is expected to be commercialized with Zimmer Biomet implants by early 2027. The acquisition expands Zimmer Biomet's offerings to include a wider range of robotics and analytics solutions, supporting surgeons throughout the entire orthopedic care pathway.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zimmer Biomet Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE91697) on October 07, 2025, and is solely responsible for the information contained therein.